Cargando…

Identification and multicentric validation of soluble CDCP1 as a robust serological biomarker for risk stratification of NASH in obese Chinese

The definitive diagnosis of non-alcoholic steatohepatitis (NASH) currently relies on invasive and labor-intensive liver biopsy. Here, we identified soluble CUB domain-containing protein 1 (sCDCP1) as a top-ranked non-invasive biomarker for NASH using Olink-based proteomics in 238 obese individuals w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Xi, Song, Erfei, Liu, Yan, Chen, Jiarui, Wan, Pei, Hu, Yue, Ye, Dewei, Chakrabarti, Subrata, Mahajan, Hema, George, Jacob, Yan, Sen, Yu, Yongtao, Zhang, Guanghui, Wang, Yong, Yang, Wah, Wu, Lihong, Hua, Shuang, Lee, Chi Ho, Li, Huixin, Jiang, Xue, Lam, Karen S.L., Wang, Cunchuan, Xu, Aimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694619/ https://www.ncbi.nlm.nih.gov/pubmed/37918406 http://dx.doi.org/10.1016/j.xcrm.2023.101257

Ejemplares similares

Stratification of patients in NASH clinical trials: A pitfall for trial success
por: Ampuero, Javier, et al.
Publicado: (2020)

Non-Invasive Risk Stratification in NAFLD/NASH Patients for Screening EGD
por: Romano, John, et al.
Publicado: (2022)

Dysregulated expression of cell surface glycoprotein CDCP1 in prostate cancer
por: Yang, Lifang, et al.
Publicado: (2015)

Identification of CD318 (CDCP1) as novel prognostic marker in AML
por: Heitmann, Jonas S., et al.
Publicado: (2020)

Anti-CDCP1 immuno-conjugates for detection and inhibition of ovarian cancer
por: Harrington, Brittney S., et al.
Publicado: (2020)

CDCP1 promotes compensatory renal growth by integrating Src and Met signaling
por: Kajiwara, Kentaro, et al.
Publicado: (2021)

Preclinical Molecular PET-CT Imaging Targeting CDCP1 in Colorectal Cancer
por: Cuda, Tahleesa J., et al.
Publicado: (2021)

Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers
por: Donahue, Katelyn L., et al.
Publicado: (2022)

Adipocyte Fatty Acid Binding Protein Promotes the Onset and Progression of Liver Fibrosis via Mediating the Crosstalk between Liver Sinusoidal Endothelial Cells and Hepatic Stellate Cells
por: Wu, Xiaoping, et al.
Publicado: (2021)

Self-induced class stratification in competitive societies of agents: Nash stability in the presence of envy
por: Gros, Claudius
Publicado: (2020)

Effective targeting of intact and proteolysed CDCP1 for imaging and treatment of pancreatic ductal adenocarcinoma
por: Kryza, Thomas, et al.
Publicado: (2020)

Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma
por: Lin, Zhiying, et al.
Publicado: (2022)

AXL/CDCP1/SRC axis confers acquired resistance to osimertinib in lung cancer
por: Murakami, Yuichi, et al.
Publicado: (2022)

Inhibition of CDCP1 by 8‐isopentenylnaringenin synergizes with EGFR inhibitors in lung cancer treatment
por: Wong, Sze‐Ching, et al.
Publicado: (2023)

Correction to ‘Self-induced class stratification in competitive societies of agents: Nash stability in the presence of envy’
por: Gros, Claudius
Publicado: (2020)

Butyrate limits inflammatory macrophage niche in NASH
por: Sarkar, Ankita, et al.
Publicado: (2023)

Methylation of microRNA-338-5p by EED promotes METTL3-mediated translation of oncogene CDCP1 in gastric cancer
por: Zhang, Fangbin, et al.
Publicado: (2021)

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers
por: Turdo, Federica, et al.
Publicado: (2016)

Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease
por: Blanco, Jose-Ramon, et al.
Publicado: (2022)

Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer
por: Zhao, Jinlu, et al.
Publicado: (2022)

CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Metastatic prostate cancer‐derived extracellular vesicles facilitate osteoclastogenesis by transferring the CDCP1 protein
por: Urabe, Fumihiko, et al.
Publicado: (2023)

CDCP1 regulates retinal pigmented epithelial barrier integrity for the development of experimental autoimmune uveitis
por: Zhang, Lingjun, et al.
Publicado: (2022)

Identification of robust and generalizable biomarkers for microbiome-based stratification in lifestyle interventions
por: Chen, Jiarui, et al.
Publicado: (2023)

CUB Domain Containing Protein 1 (CDCP1) modulates adhesion and motility in colon cancer cells
por: Orchard-Webb, David J, et al.
Publicado: (2014)

CDCP1 Identifies a CD146 Negative Subset of Marrow Fibroblasts Involved with Cytokine Production
por: Iwata, Mineo, et al.
Publicado: (2014)

Structural Requirements for Cub Domain Containing Protein 1 (CDCP1) and Src Dependent Cell Transformation
por: Kollmorgen, Gwendlyn, et al.
Publicado: (2012)

Novel small molecule inhibiting CDCP1‐PKCδ pathway reduces tumor metastasis and proliferation
por: Nakashima, Katsuhiko, et al.
Publicado: (2017)

The emerging role of the MiR-1272-ADAM9-CDCP1 signaling pathway in the progression of glioma
por: Geng, Fei, et al.
Publicado: (2020)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

Nash vek /
por: Nappelʹbaum, Moisei Solomonovich, 1869-1958
Publicado: (1984)

Nash manifolds
por: Shiota, Masahiro
Publicado: (1987)

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021)

Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis
por: Hayashi, Momoko, et al.
Publicado: (2023)

ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis
por: Chiu, Kuo-Liang, et al.
Publicado: (2015)

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer
por: Forte, Luca, et al.
Publicado: (2018)

Increased Plasma Levels of the Co-stimulatory Proteins CDCP1 and SLAMF1 in Patients With Autoimmune Endocrine Diseases
por: Magnusson, Louise, et al.
Publicado: (2020)

Targeting a proteolytic neoepitope on CUB domain containing protein 1 (CDCP1) for RAS-driven cancers
por: Lim, Shion A., et al.
Publicado: (2022)

Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progression
por: Saponaro, Miriam, et al.
Publicado: (2023)

Ascites-derived CDCP1+ extracellular vesicles subcluster as a novel biomarker and therapeutic target for ovarian cancer
por: Kong, Lingnan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e91gtuc7tfn3ojs7l9oqj8a5io